Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
29.38
-0.02 (-0.07%)
Dec 20, 2024, 4:00 PM EST - Market closed
Nutex Health Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Nutex Health stock have an average target of 55, with a low estimate of 50 and a high estimate of 60. The average target predicts an increase of 87.20% from the current stock price of 29.38.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 12, 2024.
Analyst Ratings
The average analyst rating for Nutex Health stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $45 → $50 | Strong Buy | Maintains | $45 → $50 | +70.18% | Nov 12, 2024 |
| Benchmark | Benchmark | Strong Buy Maintains $45 → $60 | Strong Buy | Maintains | $45 → $60 | +104.22% | Nov 12, 2024 |
| Maxim Group | Maxim Group | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +53.17% | Sep 18, 2024 |
| Benchmark | Benchmark | Strong Buy Maintains $30 → $45 | Strong Buy | Maintains | $30 → $45 | +53.17% | Aug 21, 2024 |
| Benchmark | Benchmark | Strong Buy Maintains $15 → $10 | Strong Buy | Maintains | $15 → $10 | -65.96% | Jan 25, 2024 |
Financial Forecast
Revenue This Year
309.45M
from 247.65M
Increased by 24.96%
Revenue Next Year
359.24M
from 309.45M
Increased by 16.09%
EPS This Year
-2.17
from -10.50
EPS Next Year
1.77
from -2.17
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 320.1M | 376.0M | 419.4M |
| Avg | 309.5M | 359.2M | 407.5M |
| Low | 295.9M | 339.4M | 391.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 29.3% | 21.5% | 16.8% |
| Avg | 25.0% | 16.1% | 13.4% |
| Low | 19.5% | 9.7% | 9.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.88 | 2.24 | 3.47 |
| Avg | -2.17 | 1.77 | 3.37 |
| Low | -2.42 | 1.32 | 3.23 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | 95.2% |
| Avg | - | - | 89.7% |
| Low | - | - | 82.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.